Perfil
Constantine Chinoporos is currently Director at Halozyme Hypercon, Inc. and will be Director at Geron Corp.
starting in 2026.
Formerly, Mr. Chinoporos was Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021, Chief Business Officer at Albireo Pharma, Inc. from 2021 to 2023, Chief Operating & Business Officer at Applied Therapeutics, Inc. from 2023 to 2026, and Head-Corporate Development at Genzyme Corp.
Education includes an undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Cargos activos de Constantine Chinoporos
| Empresas | Cargo | Inicio |
|---|---|---|
| GERON CORPORATION | Director/Miembro de la Junta | 25/03/2026 |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Constantine Chinoporos.
| Empresas | Cargo | Fin |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Director de Operaciones | 03/02/2026 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01/03/2023 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 01/10/2021 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Formación de Constantine Chinoporos.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
- Bolsa de valores
- Insiders
- Constantine Chinoporos
















